Tag: CBD
-
Vapen MJ Ventures (VAPN.C) CBD inhalers offer an alternative
Vapen MJ Ventures (VAPN.C) knows that inhalers are a perfect alternative to ingesting cannabis for people who cannot stand smoking weed, and that’s why they’ve released their line of CBD-inhalers this week. Traditionally, inhalers are associated with asthma and other respiratory ailments, but Vapen has taken the technology and bent it to their will. And…
-
What the FDA thinks of Curaleaf (CURA.C), the ‘world’s largest cannabis co.’
On July 22, 2019, the U.S. Food and Drug Administration (FDA) sent a warning letter to Curaleaf Holdings (CURA.C) via overnight delivery. The message was plain: Four of the company’s CBD-infused products are “in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act,” and Curaleaf’s CBD products for pets are “unapproved new…
-
Berz-Erka: Livewell unhalts after 8 months as Eureka 93 (ERKA.C), rolls back 15:1, loses 90% of its value
We talked to the folks behind Livewell a lot, back in the day. Seemed a good deal, certainly a team that talked a good game. Even bought a little personally. But there was always a coda attached. The projections and plans were big. Maybe too big. Here’s me, the first time I covered them. Little…
-
Plus Products (PLUS.C) dominates California edibles market
On July 17, 2019 PLUS Products (PLUS.C) announced “a new look” for its line of low dose cannabis infused edibles. It’s not intuitively obvious what was wrong with “the old look”. During Q4, 2018 Plus had three of the best-selling branded cannabis products in all categories including flower, vaporizers and edibles. According to BDS Analytics…
-
Khiron Life Sciences (KHRN.V) is still the only Colombian company with revenue from legal cannabis
Khiron Life Sciences (KHRN.C) is the only Colombian cannabis company generating revenue from legal production. We checked. After the acquisition of ILANS and the launch of the cosmeceutical brand, Kuida, Khiron is in a league of its own. There is an endless stream of cannabis companies trying to establish market share in Latin America, including…
-
Reading between the lines: Nutritional High’s (EAT.C) misplaced weed, and 1933’s (TGIF.C) respectable loss
Back in mid-2018, when everyone was talking about how MedMen (MMEN.C) was going to be the biggest weed debut ever, one of my guys looked at their listing docs, specifically under the section relating to executive compensation. What they found was egregious; the founders had all the shareholder votes, giant compensation packages, insane retention bonuses,…
-
Chemesis (CSI.C) can now grow & process hemp in the USA
If you’ve been a parent of a teenager, you’ve watched in amazement as the gangly youngster grows new limbs overnight. So it is with Chemesis International (CSI.C). “Little Puerto Rico?” asked Chris Parry rhetorically in Equity Guru’s 1st article, “Who cares?” The company – born a year ago – hit puberty while it was still…
-
Chemesis (CSI.C) QuickStrip: the Puerto Rico opportunity
Chemesis International (CSI.C) announced today that they have started selling Rapid Dose Therapeutics’ (DOSE.C) QuickStrip oral thin strips across the United States and Puerto Rico. QuickStrips is a sublingual delivery system for THC, CBD and other compounds that sports a low onset time. You pop it under your tongue and it dissolves in seconds, like…
-
The hemp shift: Livewell (LVWL.V), Heritage (CANN.C), Ascent (ASNT.C), Isodiol (ISOL.C) lead the CBD chase
If you want CBD, which is the stuff in cannabis that makes you healthier but that doesn’t get you stoned, hemp has as much of the stuff as commercial cannabis does. But hemp doesn’t attract mind boggling valuations on the public markets. On the TSX, 20k sq ft of licensed cannabis in a greenhouse in…
-
Green Organic Dutchman (TGOD.T) locks down product development tech in CBx partnership
Book it as yet another step on the march to a revenue-licious consumer products division, as The Green Organic Dutchman (TGOD.T) has announced a deal with Colorado-based CBx Enterprises to license extraction and vaporization technology for Canadian and international (non-US) markets. The deal involves Evolab and CBx Sciences products, which TGOD says positions it for…